Rockwell Medical Inc RMTI

NAS: RMTI | ISIN: US7743741024   30/04/2024
1,460 USD (-1,35%)
(-1,35%)   30/04/2024

3 augustus 2022 · Rockwell Medical to Release Second Quarter 2022 Financial Results on Monday, August 15 · Persbericht

24 juni 2022 · Rockwell Medical, Inc. Appoints Mark Strobeck, Ph.D., as President and Chief Executive Officer · Persbericht

22 juni 2022 · Rockwell Medical Provides Corporate and Clinical Update · Persbericht

7 juni 2022 · Rockwell Medical Closes $15 Million Financing from Leading Healthcare Investor · Persbericht

1 juni 2022 · Rockwell Medical Regains Compliance with Nasdaq Listing Requirements · Persbericht

31 mei 2022 · Rockwell Medical Announces $15 Million At-Market Offering · Persbericht

23 mei 2022 · Rockwell Medical, Inc. to Present at H.C. Wainwright Annual Global Life Sciences Conference · Persbericht

16 mei 2022 · Rockwell Medical Provides First Quarter 2022 Financial and Operational Update · Persbericht

12 mei 2022 · Rockwell Medical Submits Supplemental Data to FDA for IND Application for Phase 2 FPC Home Infusion Trial · Persbericht

12 mei 2022 · Rockwell Medical Announces 1-for-11 Reverse Stock Split · Persbericht

11 mei 2022 · Rockwell Medical, Inc. to Report First Quarter 2022 Financial and Operating Results on May 16, 2022 · Persbericht

25 april 2022 · Rockwell Medical Announces Completion of Patient Enrollment Ahead of Schedule in Pivotal Phase 3 Clinical Trial of Triferic® in China · Persbericht

20 april 2022 · Rockwell Medical to Present at Noblecon18 Investor Conference · Persbericht

11 april 2022 · Rockwell Medical Expands Partnership with DaVita · Persbericht

15 maart 2022 · New Survey from Rockwell Medical Reveals Management of Iron Deficiency Anemia in Home Infusion Patients Does Not Adequately Address Medical Need · Persbericht

18 maart 2021 · Rockwell Medical, Inc. to Report Fourth Quarter and Full Year 2020 Financial and Operating Results on March 31, 2021 · Persbericht

1 februari 2021 · Rockwell Medical Announces Submission of Triferic® New Drug Application in South Korea by Partner, Jeil Pharmaceutical Co., Ltd. · Persbericht

5 januari 2021 · Rockwell Medical, Inc. to Present at H.C. Wainwright BioConnect 2021 Conference · Persbericht

Mijn selecties